Additionally, proper immune function may be disrupted by the tumor microenvironment through the direct impairment of mDCs by immunosuppressive molecules such as IL-10, TGF-β, VEGF-A, and CD200 [38, 58]. The gene discussed is TGFB1; the disease is neoplasm.